Dose adjustments in renal or hepatic impairment should be guided by what?

• A. Increase dose for renal impairment
• B. Avoid all medications in hepatic impairment
• C. Use standard dosing regardless of organ function
• D. Follow organ-function-based guidelines and dosing tables

Answer: (D)

Dose adjustments in kidney or liver problems come from how these organs affect drug handling in the body. The kidneys mainly control elimination, while the liver handles metabolism. When function is reduced, drugs can stay in the body longer or be cleared more slowly, risking toxicity or loss of effect. That’s why you follow organ-function–based guidelines and dosing tables—they translate a patient’s renal or hepatic status into specific dosing recommendations, such as lowering the dose or extending the dosing interval.

In renal impairment, dosing tables use measures like creatinine clearance or eGFR to indicate how much to cut back the dose or how far apart to space doses. In hepatic impairment, metabolism can slow and protein binding can change, so guidelines (often using hepatic function classifications) show appropriate dose adjustments for drugs with narrow therapeutic windows or extensive hepatic metabolism. Drug labels and reputable resources provide these tables to standardize safe adjustments rather than relying on standard dosing.

This approach balances achieving therapeutic effect with minimizing risk, rather than assuming the same dose is appropriate for all patients regardless of organ function.